Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierStatistics In System biology and Translational Medicine [SISTM]
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorAVALOS FERNANDEZ, Marta
hal.structure.identifierStatistics In System biology and Translational Medicine [SISTM]
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorALIN, Thibaud
hal.structure.identifierStatistics In System biology and Translational Medicine [SISTM]
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMETAYER, Clemence
hal.structure.identifierStatistics In System biology and Translational Medicine [SISTM]
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorTHIEBAUT, Rodolphe
hal.structure.identifierCentre de recherche Cardio-Thoracique de Bordeaux [Bordeaux] [CRCTB]
dc.contributor.authorENAUD, Raphael
hal.structure.identifierCentre de recherche Cardio-Thoracique de Bordeaux [Bordeaux] [CRCTB]
dc.contributor.authorDELHAES, Laurence
dc.date.accessioned2023-03-07T16:31:37Z
dc.date.available2023-03-07T16:31:37Z
dc.date.issued2022-08-23
dc.identifier.issn1465-9921en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/172206
dc.description.abstractEnWhile there seems to be a consensus that a decrease in gut microbiome diversity is related to a decline in health status, the associations between respiratory microbiome diversity and chronic lung disease remain a matter of debate. We provide a systematic review and meta-analysis of studies examining lung microbiota alpha-diversity in patients with asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) or bronchiectasis (NCFB), in which a control group based on disease status or healthy subjects is provided for comparison.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enAlpha-diversity
dc.subject.enAsthma
dc.subject.enChronic obstructive respiratory disease
dc.subject.enChronic respiratory diseases
dc.subject.enCystic fibrosis
dc.subject.enFactor Analysis of Mixed Data
dc.subject.enHuman lung bacteriome
dc.subject.enHuman lung microbiome
dc.subject.enMeta-analysis
dc.subject.enNon-cystic fibrosis bronchiectasis
dc.subject.enRandom-effects models
dc.title.enThe respiratory microbiota alpha-diversity in chronic lung diseases: first systematic review and meta-analysis
dc.typeArticle de revueen_US
dc.identifier.doi10.1186/s12931-022-02132-4en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed35999634en_US
bordeaux.journalRespiratory Researchen_US
bordeaux.page214en_US
bordeaux.volume23en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamSISTM_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Respiratory%20Research&rft.date=2022-08-23&rft.volume=23&rft.issue=1&rft.spage=214&rft.epage=214&rft.eissn=1465-9921&rft.issn=1465-9921&rft.au=AVALOS%20FERNANDEZ,%20Marta&ALIN,%20Thibaud&METAYER,%20Clemence&THIEBAUT,%20Rodolphe&ENAUD,%20Raphael&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée